The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Jun 27, 2013

Keywords

ClinConnect Summary

This clinical trial is focused on collecting and reporting information about patients who are receiving hematopoietic stem cell transplants, which are treatments often used for certain types of blood cancers like leukemia and lymphoma. The goal is to gather data on the effectiveness of these treatments when they are given as standard care, helping to improve future patient care. The trial is currently looking for participants, specifically those aged 65 to 74 who are scheduled to receive either their own stem cells (autologous transplant) or stem cells from a donor (allogeneic transplant) as part of their treatment.

To be eligible for this trial, participants must be planning to undergo this standard therapy and not be involved in any other research study at the same time. Once enrolled, patients can expect to provide information about their treatment and health, which will be used to help better understand the transplant process and its outcomes. This study aims to support the overall knowledge of stem cell transplants, ultimately benefiting future patients with similar conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant
• Exclusion Criteria:
• • Participation in any other treatment research protocol